Medical Device News Magazine

Empirical Technologies Expands Location and Services

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Empirical Technologies expands its locations and services with the launch of Empirical Europe, headquartered in Belgium. Johan Van Havermaet and Xavier Deklerck are leading the company’s European presence. Van Havermaet brings a strong background in spine and emerging technologies to the team. Deklerck has built a career in foot, ankle, and trauma products. Empirical Technologies Founder Dawn Lissy said the expansion of the company she founded has been a long-term goal.

“For years, we’ve looked to Europe as a strong and natural extension of our global footprint,” she said. “For 24 years, we’ve worked to meet the needs of clients around the world. Adding Johan and Xavier to the team means we now have the right professionals in place to better serve a critical segment of the market and our industry in the European Union.” In addition to mechanical testing and Medical Device Directive to Medical Device Regulation support, the Empirical Europe team will provide regulatory support for future MDR and FDA submissions.

The Empirical Technologies engineering team has over 50 years of combined testing experience, participates actively in several ASTM committees, and has hosted FDA reviewers for Experiential Learning Program events. Empirical Technologies’ consulting experts have a proven record of regulatory success with three Breakthrough Device Designations, more than 250 FDA 510(k) clearances, and has recently added a former director of multiple FDA divisions to our panel of experts. To continue providing our clients with top-of-the-line service, our office in the United States will work closely with our office in Belgium.

The Empirical Technologies and Empirical Europe teams are ready to assist clients with their testing and regulatory needs around so they can more quickly navigate regulatory process and get devices to market quickly and efficiently. For more information, visit EmpiricalEurope.com.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”